Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji

Abstract

Adherence to SAP after screening in Fiji is currently inadequate for individual patient protection or population disease control. Secondary prevention should be strengthened before further screening can be justified.

Medication adherence of rheumatic heart disease patients: a cross-sectional study in Bangladesh

“…Nobody showed high adherence to medication. These findings are comparable to some other studies conducted in different parts of the world and Bangladesh (Engelman et al, 2016;Gasse et al, 2013;Islam and Majumder, 2016). Our result shows that walking habit (more than ten minutes at a time) (P= 0.000), exercise habit (Other than walking) (P=0.000), smoking habit (P=0.000), Duration of RHD (P=0.005) statistically significantly associated with medication adherence.…”

“…Previously, many studies have been evolved to determine the level of therapeutic compliance among rheumatic heart disease patients (de Dassel et al, 2017;Engelman et al, 2016). Adherence usually driven by multiple factors, and best understood using a system approach considering socioeconomic, healthcare, condition, therapy, and patient-related factors (WHO, 2003).…”

“…Much of the morbidity and mortality due to RHD can be prevented by existing therapies (Carapetis et al, 2013). Several old reports from developing countries have documented inadequate adherence to secondary prophylaxis and poor control of OAC therapy (Engelman et al, 2016;Oldgren et al, 2014). Therefore, our present study was conducted to determine the self-reported medication adherence by validated Bengali version of 8-item Morisky Medication Adherence Scale (MMAS-8) among rheumatic heart disease patients and determine the associated factors.…”

Screening-detected rheumatic heart disease can progress to severe disease

“…Age, sex, height and weight were recorded. Information on adherence to secondary prophylaxis was manually collected from clinic injection records, as reported elsewhere 21. Adherence was defined as the proportion of recommended BPG injections received from December 2011 to December 2014.…”

Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji

“…Cases were defined by interrogating a database compiled from individual screening activity logs in Fiji, as previously described (10). All young people aged 5 -15 years who were diagnosed with RHD on echocardiographic screening from 2006 -2013 and recommended to commence secondary prophylaxis were included in the primary cohort (11)(12)(13).…”